Examination of the safety of Moviprep in elderly people and dialysis patients

Examination of the safety of Moviprep in elderly people and dialysis patients - Examination of the safety of Moviprep in elderly people and dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015724

Enrollment

150

Registered

2014-11-20

Start date

2014-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patient who have colonoscopy

Interventions

Moviprep (It is Niflec administration when undergoing the 2nd colonoscopy)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are tolerated to colonoscopy and Moviprep preparation. Patients who has informed consents.

Exclusion criteria

Exclusion criteria: Patients of contraindications to Niflec or Moviprep

Design outcomes

Primary

Measure	Time frame
Influences of Moviprep to blood test data, vital sign, weight etc.	—

Countries

Japan

Contacts

Public ContactNoriyoshi Ogino

University of Occupational and Environmental Health Third Department of Internal Medicine

n-ogino@med.uoeh-u.ac.jp093-603-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026